Valeo Financial Advisors, LLC Incyte Corp Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$79.87 - $87.53 $3,993 - $4,376	-50 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$85.07 - $109.69 $3,232 - $4,168	-38 Reduced 43.18%	50 $4,000
Q2 2020 Jul 20, 2020	BUY	$74.18 - $108.93 $2,818 - $4,139	38 Added 76.0%	88 $9,000
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $6,085 - $8,398	-100 Reduced 66.67%	50 $3,000
Q4 2017 Feb 09, 2018	SELL	$93.56 - $116.6 $46,780 - $58,300	-500 Reduced 76.92%	150 $14,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $70,947 - $89,875	650	650 $76,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.